EMD Serono
Subsidiary of Merck KGaA (MKKGY)
Assets
(2 total)
2Total Assets
2Approved
0Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | Interferon beta receptor (type I IFN signaling) · Type I interferon receptorBiologic (subtype unspecified) | Multiple Sclerosis | |
Somatropin(Serostim) | Approved | Growth hormone receptorProtein / enzyme therapeutic | HIV |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.